Proteogenomic and metabolomic characterization of human glioblastoma

Wang, Liang-Bo, Karpova, Alla, Gritsenko, Marina A., Kyle, Jennifer E., Cao, Song, Li, Yize, Rykunov, Dmitry, Colaprico, Antonio +230 more·2021·Cancer Cell
DOI 10.1016/j.ccell.2021.01.006

Cited by (656)

Items 201–300 of 656

  1. Pan-Cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer Therapeutics
    Jixin Wang, Wen Yu, Rachel K. D’Anna, Anna Przybyła, Matt Wilson, Matthew S. Sung, John Bullen, Elaine M. Hurt, Gina D’Angelo, Ben S. Sidders et al. · 2023 · Molecular & Cellular Proteomics
  2. CD8 + CD103 + PD1 + TIM3 + T cells in glioblastoma microenvironment correlate with prognosis
    Giulia Romagnoli, Quintino Giorgio D’Alessandris, Imerio Capone, Andrea Tavilla, Irene Canini, Caterina Lapenta, Mariachiara Buccarelli, Martina Giordano, Valentina Tirelli, Massimo Sanchez et al. · 2023 · Immunology
  3. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma
    Takahide Nejo, Lin Wang, Kevin Leung, Albert Wang, Senthilnath Lakshmanachetty, Marco Gallus, Darwin W. Kwok, Chibo Hong, Lee H. Chen, Diego A. Carrera et al. · 2024 · Scientific Reports
  4. CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells
    Shuchang Zhou, Weiwei Lin, Xiong Jie Jin, Rui Niu, Zheng Yuan, Tianran Chai, Qi Zhang, Meixia Guo, Sung Soo Kim, Meichen Liu et al. · 2024 · Cell Reports Medicine
  5. Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1
    Chen Zhao, Yingwei Li, Chunping Qiu, Jingying Chen, Huan Wu, Qiuman Wang, Xinyue Ma, Kun Song, Beihua Kong · 2021 · Frontiers in Oncology
  6. Predicting gene and protein expression levels from DNA and protein sequences with Perceiver
    Matteo Stefanini, Marta Lovino, Rita Cucchiara, Elisa Ficarra · 2023 · Computer Methods and Programs in Biomedicine
  7. Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
    Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer A, Amankeldi A. Salybekov, Markus Wolfien · 2025 · Epigenomes
  8. Extracellular vesicle-derived miRNA-mediated cell–cell communication inference for single-cell transcriptomic data with miRTalk
    Xin Shao, Lingqi Yu, Chengyu Li, Jingyang Qian, Xinyu Yang, Haihong Yang, Jie Liao, Xueru Fan, Xiao Xu, Xiaohui Fan · 2025 · Genome biology
  9. Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
    Changping Deng, Shihui Li, Yuping Liu, Wen Bao, Chengnan Xu, Wenyun Zheng, Meiyan Wang, Xingyuan Ma · 2023 · Clinical and Translational Medicine
  10. Microneedle Patch Delivery of PLCG1-siRNA Efficient Enhanced Temozolomide Therapy for Glioblastoma
    Zhipeng Yang, Yanjie Liu, Haoyuan Li, Qisheng Tang, Biao Yang, Zhifeng Shi, Ying Qing Mao · 2024 · Biomacromolecules
  11. Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy
    Yuqing Ren, Yi Yue, Xinyang Li, Siyuan Weng, Hui Xu, Long Liu, Quan Cheng, Peng Luo, Tengfei Zhang, Zaoqu Liu et al. · 2024 · International Immunopharmacology
  12. Multi-Omics Advancements towards Plasmodium vivax Malaria Diagnosis
    Shalini Aggarwal, Weng Kung Peng, Sanjeeva Srivastava · 2021 · Diagnostics
  13. Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
    Andra Valentina Krauze, Yingdong Zhao, Ming‐Chung Li, Joanna H. Shih, Will M. Jiang, Erdal Taşçı, Theresa Cooley Zgela, Mary T. Sproull, Megan A. Mackey, Uma T. Shankavaram et al. · 2023 · Biomolecules
  14. Panoramic spatial enhanced resolution proteomics (PSERP) reveals tumor architecture and heterogeneity in gliomas
    Ziyan Xu, Yunzhi Wang, Tao Xie, Rongkui Luo, Hengli Ni, Xiang Hang, Shaoshuai Tang, Subei Tan, Rundong Fang, Peng Ran et al. · 2025 · Journal of Hematology & Oncology
  15. Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations
    Robert K. Suter, Anna M. Jermakowicz, Rithvik Veeramachaneni, Matthew D’Antuono, L.G. Zhang, Rishika Chowdary, Simon Kaeppeli, Madison Sharp, Pravallika Palwai, Vasileios Stathias et al. · 2026 · Nature Communications
  16. LncRNA SNHG25 Promotes Glioma Progression Through Activating MAPK Signaling
    Zeyu Wu, Peng Lun, Tao Ji, Jiaojiao Niu, Xiuyan Sun, Xia Liu, Jian Yu Xu · 2022 · Molecular Neurobiology
  17. Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism
    Miguel Cosenza‐Contreras, Agnes Schäfer, Justin Sing, Lena Cook, Maren Nicole Stillger, Chia-Yi Chen, José Villacorta Hidalgo, Niko Pinter, Larissa Alejandra Meyer, Tilman Werner et al. · 2023 · Neuro-Oncology
  18. MiR-128-3p – a gray eminence of the human central nervous system
    Kiel, Klaudia, Król, Sylwia Katarzyna, Bronisz, Agnieszka, Godlewski, Jakub · 2024 · Molecular Therapy Nucleic Acids
  19. Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone
    Emily S. Norton, Lauren A. Whaley, Vanessa K. Jones, Mieu Brooks, Marissa N. Russo, Dmytro Morderer, Erik Jessen, Paula V. Schiapparelli, Andres Ramos‐Fresnedo, Natanael Zarco et al. · 2024 · Science Advances
  20. The Open Pediatric Cancer Project
    Zhuangzhuang Geng, Eric K. Wafula, Ryan J. Corbett, Yuanchao Zhang, Run Jin, Krutika Satish Gaonkar, Sangeeta Shukla, Komal S. Rathi, Dave D. Hill, Aditya Lahiri et al. · 2025 · GigaScience
  21. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
    Yu Zeng, Yonghua Cai, Peng Chai, Yangqi Mao, Yanwen Chen, Li Wang, Kunlin Zeng, Ziling Zhan, Yuxin Xie, Cuiying Li et al. · 2022 · Frontiers in Immunology
  22. Restraint of cancer cell plasticity by spatial homotypic clustering
    Simona Migliozzi, Bruno Adabbo, Luciano Garofano, Fan Wu, Pedro Davila, Ricardo J. Komotar, Michael E. Ivan, Ashish Harish Shah, Benjamin Currall, Siôn Llewelyn Williams et al. · 2025 · Cancer Cell
  23. An Interpretable Machine Learning Model for Predicting 5‐Year Survival in Breast Cancer Based on Integration of Proteomics and Clinical Data
    Zhixuan Wu, Shengnan Yao, Lingli Jin, Xue Wu, Rongrong Zhang, Ouchen Wang, Erjie Xia · 2025 · iMetaMed
  24. Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications
    Shantel M. Angstadt, Qingfeng Zhu, Elizabeth M. Jaffee, Douglas N. Robinson, Robert A. Anders · 2022 · Frontiers in Oncology
  25. Proteogenomic Analysis of Breast Cancer Transcriptomic and Proteomic Data, Using De Novo Transcript Assembly: Genome-Wide Identification of Novel Peptides and Clinical Implications
    Parameswaran Hari, Lavanya Balakrishnan, Chaithanya Kotyada, Arivusudar Everad John, Shivani Tiwary, Nameeta Shah, Ravi Sirdeshmukh · 2022 · Molecular & Cellular Proteomics
  26. Mechanisms Underlying the Promoting Effects of 3D Collagen Scaffold Culture on Stemness and Drug Resistance of Glioma Cells
    Wei Jia, Hecheng Zhu, Ming Zhao, Quanwei Zhou, Wen Yin, Weidong Liu, Lei Wang, Zhifeng Xiao, Xingjun Jiang, Jianwu Dai et al. · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  27. Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
    Silvana Andrea Mouron, María J. Bueno, Ana M. Lluch, Luís Manso, Isabel Calvo, Javier Cortés, José Á. García-Sáenz, Miguel Gil‐Gil, Noelia Martínez-Jáñez, Juan V. Apala et al. · 2022 · Nature Communications
  28. Divergent transcriptomic signatures from putative mesenchymal stimuli in glioblastoma cells
    William S. Hart, Paul J. Myers, Benjamin W. Purow, Matthew J. Lazzara · 2024 · Cancer Gene Therapy
  29. Target Reprogramming the 3′UTR of Tumor‐Suppressor Genes by a siRNA Composite Nanoparticle for Glioblastoma Therapy
    Bin Gu, Xianyan Zeng, Ming Gong, Xiangyu Li, Qian Yu, Zhengzong Tan, Zheqi Lou, Tinghui Jiang, Yu Che, Yiran Ao et al. · 2024 · Advanced Functional Materials
  30. Research progress on S-palmitoylation modification mediated by the ZDHHC family in glioblastoma
    Beiyan Tang, Wei Cherng Malvin Kang, Qiang Dong, Zhenwei Qin, Lei Duan, Xianjun Zhao, Guoqiang Yuan, Yawen Pan · 2024 · Frontiers in Cell and Developmental Biology
  31. Histological Studies of the Ventricular–Subventricular Zone as Neural Stem Cell and Glioma Stem Cell Niche
    Asa A. Brockman, Bret C. Mobley, Rebecca A. Ihrie · 2021 · Journal of Histochemistry & Cytochemistry
  32. The Brain Protein Atlas: A conglomerate of proteomics datasets of human neural tissue
    K. H. Brian Lam, Kevin Faust, Richard Yin, Clare Fiala, Phedias Diamandis · 2022 · PROTEOMICS
  33. Deep Learning and Its Applications in Computational Pathology
    Hong, Runyu, Fenyö, David · 2022 · BioMedInformatics
  34. Statistical Detection of Differentially Abundant Proteins in Experiments with Repeated Measures Designs and Isobaric Labeling
    Ting C. Huang, Mateusz Staniak, Felipe da Veiga Leprevost, Amanda M. Figueroa‐Navedo, Alexander R. Ivanov, Alexey I. Nesvizhskii, Meena Choi, Olga Vitek A · 2023 · Journal of Proteome Research
  35. A review on trends in development and translation of omics signatures in cancer
    Wei Ma, Wenshu Tang, Jamie Sui-Lam Kwok, Amy H.Y. Tong, Cario W.S. Lo, Annie Tsz-Wai Chu, Brian Hon‐Yin Chung, Hong Kong Genome Project · 2024 · Computational and Structural Biotechnology Journal
  36. DNA methylation heterogeneity attributable to a complex tumor immune microenvironment prompts prognostic risk in glioma
    Shuangyue Ma, Pan Xu, Jing Gan, Xiaxin Guo, Jiaheng He, Haoyu Hu, Yuncong Wang, Shangwei Ning, Hui Zhi · 2024 · Epigenetics
  37. GPT-4 as a biomedical simulator
    Moritz Schaefer, Stephan Reichl, Rob ter Horst, Adele M. Nicolas, Thomas Krausgruber, Francesco Piras, Peter Stepper, Christoph Bock, Matthias Samwald A · 2024 · Computers in Biology and Medicine
  38. Current progress of anti‑PD‑1/PDL1 immunotherapy for glioblastoma (Review)
    Jianheng Wu, Nannan Wang · 2024 · Molecular Medicine Reports
  39. The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives
    Yashwanth Subbannayya, Riccardo Di Fiore, Silvana Anna Maria Urru, Jean Calleja‐Agius · 2021 · Biomedicines
  40. Comprehensive omics analyses profile genesets related with tumor heterogeneity of multifocal glioblastomas and reveal LIF/CCL2 as biomarkers for mesenchymal subtype
    Shengqing Lv, Zhen Fang Fu, Lin Yang, Qingrui Li, Jiang Zhu, Qu‐Jing Gai, Min Mao, Jiang He, Yan Qin, Xiao‐Xue Yao et al. · 2021 · Theranostics
  41. Inflammation-related citrullination of matrisome proteins in human cancer
    Pekka Rappu, Ujjwal Suwal, Elina Siljamäki, Jyrki Heino · 2022 · Frontiers in Oncology
  42. Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
    Xinzhuang Wang, Hong Zhang, Mingchu Zhang, Xuezhi Zhang, Wenbin Mao, Ming Gao · 2023 · BMC Cancer
  43. An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5
    Tamara Lah Turnšek, Xuanmao Jiao, Metka Novak, Sriharsha Jammula, Gina Cicero, Anthony W. Ashton, David A. Joyce, Richard G. Pestell · 2021 · International Journal of Molecular Sciences
  44. HAVOC: Small-scale histomic mapping of cancer biodiversity across large tissue distances using deep neural networks
    Anglin Dent, Kevin Faust, K. H. Brian Lam, Narges Alhangari, Alberto Jose Leon, Queenie Tsang, Zaid Saeed Kamil, Andrew F. Gao, Prodipto Pal, Stéphanie Lheureux et al. · 2023 · Science Advances
  45. Pan‐cancer proteogenomic landscape of whole‐genome doubling reveals putative therapeutic targets in various cancer types
    Eunhyong Chang, Su‐Jung Kim, Hee Sang Hwang, Kyu Jin Song, Kwoneel Kim, Min‐Sik Kim, Se Jin Jang, Sungyong You, Kwang Pyo Kim, Joon‐Yong An · 2024 · Clinical and Translational Medicine
  46. Opportunities and Challenges of Small Molecule Inhibitors in Glioblastoma Treatment: Lessons Learned from Clinical Trials
    Linde Hoosemans, Marc Vooijs, Ann Hoeben · 2024 · Cancers
  47. Blood and cerebrospinal fluid biomarkers in neuro-oncology
    Roberta Rudà, Alessia Pellerino, Riccardo Soffietti · 2024 · Current Opinion in Neurology
  48. Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma
    Derek Wong, Tae Hoon Lee, Amy M. Lum, Valerie Lan Tao, Stephen S. F. Yip · 2022 · Acta Neuropathologica Communications
  49. Angiogenesis goes computational – The future way forward to discover new angiogenic targets?
    Abhishek Subramanian, Pooya Zakeri, Mira Mousa, Halima Alnaqbi, Fatima Yousif Alshamsi, Leo Bettoni, Ernesto Damiani, Habiba S. AlSafar, Yvan Saeys, Peter Carmeliet · 2022 · Computational and Structural Biotechnology Journal
  50. Variant biomarker discovery using mass spectrometry-based proteogenomics
    Luke Reilly, Sahba Seddighi, A. Singleton, M. Cookson, M. Ward, Yue A. Qi · 2023 · Frontiers in Aging
  51. Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas
    Francesca De Bacco, Francesca Orzan, Giovanni Crisafulli, Marta Prelli, Claudio Isella, Elena Casanova, Raffaella Albano, Gigliola Reato, Jessica Erriquez, Antonio D’Ambrosio et al. · 2023 · Cell Reports
  52. Overexpression of CD99 is associated with tumor adaptiveness and indicates the tumor recurrence and therapeutic responses in gliomas
    Erfei Shang, Shanyue Sun, Ruolan Zhang, Zehui Cao, Qingwang Chen, Leming M. Shi, Jinsong Wu, Shuai Wu, Yingchao Liu, Yuanting Zheng · 2023 · Translational Oncology
  53. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma
    Zhiyuan Liu, Songtao Wang, Kuo Yu, Kaile Chen, Liang Zhao, Jiayue Zhang, Kexiang Dai, Peng Zhao · 2023 · Journal of Translational Medicine
  54. The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research
    Nina Yu, Orwa Aboud · 2024 · Cancers
  55. A perspective on integrating digital pathology, proteomics, clinical data and AI analytics in cancer research
    Guedes, Jéssica, Woldmar, Nicole, Szasz, A. Marcell, Wieslander, Elisabet, Pawłowski, Krysztof, Horvatovich, Peter, Malm, Johan, Szadai, Leticia, Németh, István Balázs, Marko-Varga, György et al. · 2025 · Journal of Proteomics
  56. Astrocytes in neuroinflammation and brain cancer
    Wei Sun, Pin Chen, Xiaoyin Xu, Jia-Qi Zhang, Weilin Jin · 2026 · Molecular Biomedicine
  57. Spatial and single-cell characterization of human glioblastoma tumor microenvironment reveals malignant cellular communities
    Jun Lin, Chunpeng Chen, Shouzhen Li, Liu Chen, Minghao Fang, Shuqi Fu, Kaixing Chen, HJ Xu, Fenghuan Zhang, Rirui Wang et al. · 2026 · Nature Neuroscience
  58. Metabolic remodeling in astrocytes: Paving the path to brain tumor development
    Myriam Jaraíz-Rodríguez, Lucia del Prado, Eduardo Balsa · 2023 · Neurobiology of Disease
  59. Multiomics in cancer biomarker discovery and cancer subtyping
    Seunghwan Choi, Joon‐Yong An · 2024 · Advances in clinical chemistry
  60. Role of GPX3+ astrocytes in breast cancer brain metastasis activated by circulating tumor cell exosomes
    Guanghui Huang, Gongwen Xu, Qianqian Cao, Sheng Li, Zhengwei Li, Xiaonan Zhang, Xiaomei Li · 2025 · npj Precision Oncology
  61. Protein kinase Cι and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities
    Rajappa S. Kenchappa, Yi Liu, Michael Argenziano, Matei A. Banu, Ann C. Mladek, Rita West, Amanda Luu, Alfredo Quiñones‐Hinojosa, Dolores Hambardzumyan, Verline Justilien et al. · 2021 · Cell Reports
  62. The MAP3K1/c-JUN signaling axis regulates glioblastoma stem cell invasion and tumor progression
    Shuchang Zhou, Rui Niu, Han Sun, Sung-Hak Kim, Xiong Jie Jin, Jinlong Yin · 2022 · Biochemical and Biophysical Research Communications
  63. The current state of glioma data registries
    Alexander G. Yearley, Julian Bryan Iorgulescu, Ennio Antonio Chiocca, Pier Paolo Peruzzi, Timothy Richard Smith, David A. Reardon, Michael A. Mooney · 2022 · Neuro-Oncology Advances
  64. Spinal Metastasis in a Patient with Supratentorial Glioblastoma with Primitive Neuronal Component: A Case Report with Clinical and Molecular Evaluation
    Michal Hendrych, Peter Solar, Markéta Hermanová, Ondřej Slabý, Hana Valeková, Marek Večeřa, Alena Kopková, Zdeněk Mackerle, Tomáš Kazda, Petr Pospíšil et al. · 2023 · Diagnostics
  65. MUC17 mutations and methylation are associated with poor prognosis in adult-type diffuse glioma patients
    Gabriel Cardoso Machado, Valéria Pereira Ferrer · 2023 · Journal of the Neurological Sciences
  66. Regulation of cancer stem cells and immunotherapy of glioblastoma (Review)
    Aleksandra A. Kosianova, Oleg Pak, Igor Bryukhovetskiy · 2023 · Biomedical Reports
  67. The Contribution of Oxidative Stress to NF1-Altered Tumors
    Elisabetta Kuhn, Federica Natacci, Massimo Corbo, Luigi Pisani, Stefano Ferrero, Gaetano Bulfamante, Donatella Gambini · 2023 · Antioxidants
  68. Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
    Żaneta Kałuzińska‐Kołat, Damian Kołat, Katarzyna Kośla, Elżbieta Płuciennik, Andrzej Kazimierz Bednarek · 2023 · Frontiers in Neuroscience
  69. Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic Genes
    Akshitkumar M. Mistry, Jonah C. Daneshmand, SeonYeong Jamie Seo, Norman L. Lehman, Donald Max Miller, Dylan A. Goodin, Hermann B. Frieboes, Joseph Chen, Adrianna Henson Masters, Brian J. Williams et al. · 2024 · Current Oncology
  70. Intratumoral Cell Heterogeneity in Patient-Derived Glioblastoma Cell Lines Revealed by Single-Cell RNA-Sequencing
    Mikhail S. Arbatskiy, Dmitriy E. Balandin, Alexey Viktorovich Churov, V. O. Varachev, Eugenia Nikolaeva, Alexei Mitrofanov, A. Кh. Bekyashev, О. Н. Ткачева, Olga Yu. Susova, Tatiana V. Nasedkina · 2024 · International Journal of Molecular Sciences
  71. Identification of energy metabolism anomalies and serum biomarkers in the progression of premature ovarian failure via extracellular vesicles’ proteomic and metabolomic profiles
    Zhen Liu, Qilin Zhou, Liangge He, Zhengdong Liao, Yajing Cha, Hongyu Zhao, Wenchao Zheng, Desheng Lu, Sheng Yang · 2024 · Reproductive Biology and Endocrinology
  72. Sex differences in the molecular profile of adult diffuse glioma are shaped by IDH status and tumor microenvironment
    Yingbo Huang, Yuting Shan, Weijie Zhang, Christina Printzis, Lorenzo L. Pesce, Danielle Stover, Catherine Stanhope, Barbara E. Stranger, R. Stephanie Huang · 2024 · Neuro-Oncology
  73. Lipidomics-driven drug discovery and delivery strategies in glioblastoma
    Xiaohui Weng, Michael Gonzalez, Jeannes Angelia, Somayeh Piroozmand, Saleh Jamehdor, Amir Barzegar Behrooz, Hamid Latifi‐Navid, Mazaher Ahmadi, Stevan Pecic · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  74. Non-invasive liquid biopsy based on metabolomic profiling improves diagnosis and early warning of severe acute pancreatitis
    Deng Da, Qihang Yuan, Pan Chen, Junhong Chen, Jianjun Liu, Song Wei, Yi Liu, YuTong Zhu, Tianfu Wei, Jianliang Cao et al. · 2026 · npj Digital Medicine
  75. Analysis of isobaric quantitative proteomic data using TMT-Integrator and FragPipe computational platform
    Hui-Yin Chang, Yamei Deng, Ruohong Li, Dmitry M. Avtonomov, Bo Wen, Sarah Haynes, Felipe da Veiga Leprevost, Bing Zhang, Fengchao Yu, Alexey I. Nesvizhskii · 2026 · Nature Communications
  76. OSppc: A web server for online survival analysis using proteome of pan-cancers
    Lu Zhang, Qiang Wang, Yali Han, Yingsa Huang, Tianhui Chen, Xiangqian Guo · 2022 · Journal of Proteomics
  77. Epigenetic and transcriptional activation of the secretory kinase FAM20C as an oncogene in glioma
    Bo Gong, Yi Chu Liang, Qian Zhang, Huan Li, Jialing Xiao, Liang Wang, Han Chen, Wenjie Yang, Xiaoqing Wang, Yi Wang et al. · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
  78. Recent advances in understanding brain cancer metabolomics: a review
    Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan, Rama Jayaraj, Raja Ganesan, Kaviyarasi Renu, Balachandar Vellingiri, Abhijit Dey, Mohamudha Parveen Rahamathulla · 2023 · Medical Oncology
  79. Co-amplification of CBX3 with EGFR or RAC1 in human cancers corroborated by a conserved genetic interaction among the genes
    Giuseppe Bosso, Francesca Cipressa, Liliana Tullo, Giovanni Cenci · 2023 · Cell Death Discovery
  80. Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies
    Alberto Visioli, Nadia Trivieri, Gandino Mencarelli, Fabrizio Giani, Massimiliano Copetti, Orazio Palumbo, Riccardo Pracella, Maria Grazia Cariglia, Chiara Barile, Luigi Mischitelli et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  81. T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis
    Zhongqi Fan, Yutao Liu, Chengcheng Li, Yanfang Jiang, Nanya Wang, Ming-Da Wang, Chao Li, Yong‐Kang Diao, Wei Qiu, Zhu Xin et al. · 2023 · iScience
  82. Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment
    Vassilis Genoud, Ben Kinnersley, Nicholas Fraser Brown, Diego Ottaviani, Paul James Mulholland · 2023 · Cancers
  83. Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
    Andra Valentina Krauze, Michael L. Sierk, Trinh Nguyen, Qingrong Chen, Chunhua Yan, Ying Hu, William Jiang, Erdal Taşçı, Theresa Cooley Zgela, Mary T. Sproull et al. · 2023 · Frontiers in Oncology
  84. Multi-omics analysis of Nicotiana tabacum unveils tissue-specific regulatory expression strategies for cadmium accumulation
    Xueao Zheng, Chen Wang, Yalong Xu, Zhengzhong Kang, Peijian Cao, Haitao Zhang, Qiansi Chen · 2024 · Industrial Crops and Products
  85. PhosCancer: A comprehensive database for investigating protein phosphorylation in human cancer
    Qun Dong, Danqing Shen, Jiachen Ye, Jiaxin Chen, Jing Li · 2024 · iScience
  86. Uncovering metabolic signatures in cancer-derived exosomes: LC-MS/MS and NMR profiling
    Nandini Bajaj, Deepika Sharma · 2024 · Nanoscale
  87. Deciphering the contributions of fecal microbiota from patients with high-grade glioma to tumor development in a humanized microbiome mouse model of glioma
    Cheng Wang, Yiqi Fan, Lu Zhang, Zhanyi Zhao, Feiyang Luo, Kaijian Sun, Meiqin Zeng, Hao Tian, Meichang Peng, Yunhao Luo et al. · 2025 · Neuro-Oncology Advances
  88. Innovative Therapeutic Strategies Targeting the Network Architecture of Glioblastoma
    Julius Beichert, Dirk C. Hoffmann, Frank Winkler, Miriam Ratliff · 2025 · Clinical Cancer Research
  89. Integrative proteogenomic characterization of Wilms tumor
    Cheng Cheng, Li Zhang, Xiaofeng Chang, Kai Chen, He Tian, Jia Shi, Fan Lv, Lijia Pan, Yangkun Wu, Qianqian Cheng et al. · 2025 · Nature Communications
  90. Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma
    Jana de Sostoa, Eliana Marinari, Martin Pédard, Valérie Widmer, Suzel Davanture, Karl Schaller, Stéphanie R. Tissot, Michele De Palma, Benita Wolf, Gertraud Orend et al. · 2025 · Journal for ImmunoTherapy of Cancer
  91. Cancer cell histone density links global histone acetylation, mitochondrial proteome and histone acetylase inhibitor sensitivity
    Christopher Bruhn, Giulia Bastianello, Marco Foiani · 2022 · Communications Biology
  92. The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single-Cell Analysis
    Haoteng Yan, Jiali Zhu, Yanyan Ping, Min Yan, Gaoming Liao, Huating Yuan, Yao Zhou, Fengyu Xiang, Bo Pang, Jinyuan Xu et al. · 2022 · Stem Cells
  93. Proteogenomics in Cancer: Then and Now
    Xiuyun Wang, Yan‐Ming Xu, Andy T. Y. Lau · 2023 · Journal of Proteome Research
  94. Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma
    Elham Ali, Marwa Adel Ahmed, May Ahmed Shawki, Lobna R. Ezz El Arab, Mohamed K. Khalifa, Menha M. Swellam · 2025 · Scientific Reports
  95. Mechanism analysis and targeted therapy of IDH gene mutation in glioma
    Xingyuan Ma · 2025 · American Journal of Cancer Research
  96. IDSL.UFA Assigns High-Confidence Molecular Formula Annotations for Untargeted LC/HRMS Data Sets in Metabolomics and Exposomics
    ‪Sadjad Fakouri Baygi‬, Sanjay Kumar Banerjee, Praloy Chakraborty, Yashwant Kumar, Dinesh Kumar Barupal · 2022 · Analytical Chemistry
  97. Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer
    Hidekazu Hirano, Yuichi Abe, Yosui Nojima, Masahiko Aoki, Hirokazu Shoji, Junko Isoyama, Kazufumi Honda, Narikazu Boku, Kenji Mizuguchi, Takeshi Tomonaga et al. · 2022 · Scientific Reports
  98. MONTE enables serial immunopeptidome, ubiquitylome, proteome, phosphoproteome, acetylome analyses of sample-limited tissues
    Jennifer G. Abelin, Erik J. Bergstrom, Hannah B. Taylor, Keith D. Rivera, Susan Klaeger, Charles Xu, C. Jackson White, Meagan E. Olive, Myranda Maynard, M. Harry Kane et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes
    Thanasupawat, Thatchawan, Glogowska, Aleksandra, Pascoe, Christopher, Krishnan, Sai Nivedita, Munir, Maliha, Begum, Farhana, Beiko, Jason, Krcek, Jerry, Del Bigio, Marc R., Pitz, Marshall et al. · 2021 · International Journal of Molecular Sciences
  100. Immune landscape-based machine-learning–assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma
    Haiyan Li, Jian G. He, Menglong Li, Kun Li, Xuemei Pu, Yanzhi Guo · 2022 · Frontiers in Immunology